Silvio Almeida-Junior

Prof. Dr. Silvio Almeida-Junior

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2023 in Fundamental & Clinical Pharmacology
Verified
Journal Article
Closed access
SASilvio Almeida-Junior
Silvio Almeida-Junior
MFMatheus Vitor Ferreira Ferraz
Matheus Vitor Ferreira Ferraz
AOAlex Roberto de Oliveira
Alex Roberto de Oliveira
FMFabíola Pansani Maniglia
Fabíola Pansani Maniglia
JBJairo Kenupp Bastos
Jairo Kenupp Bastos
RFRicardo Andrade Furtado
Ricardo Andrade Furtado

1 January 2020 in Brazilian Journal of Health Review
Verified
Journal Article
Open access
PDF file
SASilvio Almeida-Junior
Silvio Almeida-Junior
RKRodolpho César Oliveira Mellem Kairala
Rodolpho César Oliveira Mellem Kairala
APAmanda Garcia Pereira
Amanda Garcia Pereira
GCGuilherme Barbosa da Costa
Guilherme Barbosa da Costa
RCRoberta Cristina Ribeiro Cruz
Roberta Cristina Ribeiro Cruz
RFRicardo Andrade Furtado
Ricardo Andrade Furtado
COVID-19 e a infecção por SARS-CoV-2 em um panorama geral/ COVID-19 and infection by SARS-CoV-2 in an overview

17 September 2020 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
SASilvio Almeida-Junior
Silvio Almeida-Junior
DPDanielle Vieira Pereira
Danielle Vieira Pereira
TFThuany Martins Ferreira
Thuany Martins Ferreira
RFRenato Alves de Freitas
Renato Alves de Freitas
CSCarina Coimbra Silva
Carina Coimbra Silva
RFRicardo Andrade Furtado
Ricardo Andrade Furtado
The Brazilian green propolis is produced by Apis mellifera from Baccharis dracunculifolia. Kaempferide, which was isolated from green propolis and B. dracunculifolia is an O-methylated flavonol bearing gastroprotective, anti-allergic and anti-hypertensive activities. Thus, the aim of this study was to evaluate the anti-inflammatory and antinociceptive potentials of kaempferide, as well as its possible toxicological effect on kidney and liver. For that, nociception was assessed by thermal (hargreaves apparatus) and mechanical (Dynamic Plantar Aesthesiometer) sensitivities; anti-inflammatory potential was assessed by carrageenan induced edema; and the toxicological profile was assessed by blood biochemical assessment. Kaempferide significantly reduced mechanical nociception and displayed anti-inflammatory effect, which was evidenced by the reduction of the volume of the paw edema, as well as by the reduction of infiltrates, cellularity and area of the injured tissue. On the other hand, it was inactive in the thermal nociception protocol either with or without an inflammatory process, as well as it was inactive in the mechanical nociception protocol after an inflammatory process. In addition, central nervous system depression, liver and kidney toxicities were not observed.

21 September 2023 in Fundamental & Clinical Pharmacology
Verified
Journal Article
Closed access
RFRicardo Andrade Furtado
Ricardo Andrade Furtado
SRSamir Anis Ross
Samir Anis Ross
SASilvio Almeida-Junior
Silvio Almeida-Junior
RMRafael Paranhos de Mendonça
Rafael Paranhos de Mendonça
CBCristiane Teixeira Vilhena Bernardes
Cristiane Teixeira Vilhena Bernardes
JBJairo Bastos
Jairo Bastos

2 July 2025 in Journal of Pharmacological and Toxicological Methods
Verified
Journal Article
Closed access
JSJhonatan Felipe dos Santos
Jhonatan Felipe dos Santos
MPMaria Eduarda Dias Possate
Maria Eduarda Dias Possate
MAMaysa Barbosa de Almeida
Maysa Barbosa de Almeida
EMEveline Maria de Melo
Eveline Maria de Melo
RFRicardo Andrade Furtado
Ricardo Andrade Furtado
SASilvio Almeida-Junior
Silvio Almeida-Junior

22 May 2025 in Toxicology Reports
Verified
Journal Article
Open access
MPMarcelo Henrique de Paiva
Marcelo Henrique de Paiva
SASilvio Almeida-Junior
Silvio Almeida-Junior
CGCristiane Buzatto Garcia
Cristiane Buzatto Garcia
PPPoliana Marques Pereira
Poliana Marques Pereira
JMJoão Guilherme Martins
João Guilherme Martins
DJDaniel Paulino Junior
Daniel Paulino Junior
The use of chemotherapeutic agents, such as doxorubicin, is often associated with severe adverse effects, making it essential to develop therapeutic strategies that can attenuate or reduce their toxicity. This study aimed to investigate the effects of omega-3 in mitigating the damage induced by doxorubicin. Rabbits received doxorubicin (1 mg/kg, twice weekly for six weeks) with or without omega-3 (500, 1000, or 2000 mg/kg), administered concomitantly. An additional group received omega-3 alone (2000 mg/kg). Hematological, biochemical, genotoxic (micronucleus assay), cardiological (electrocardiogram, echocardiogram, and markers), and histopathological parameters were assessed. Os resultados mostraram que o tratamento com doxorrubicina isolada induziu caquexia nos animais. O tratamento com ômega-3 melhora parâmetros como ganho de peso, fração de ejeção cardíaca, encurtamento sistólico ventricular, marcadores cardíacos CK-MB e Troponina I, área do ventrículo esquerdo e parâmetros histopatológicos (inflamação, edema, dano celular e fibras musculares), sugerindo um efeito protetor. Além disso, o ômega-3 exibiu atividade antigenotóxica, evidenciada pela redução de micronúcleos. Esses achados indicam que o ômega-3 pode servir como um complemento eficaz à quimioterapia, reduzindo a toxicidade da doxorrubicina.